Free Subscription

  • Access daily briefings and unlimited news articles

Premium

Try one month for $34.95
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis

Johnson & Johnson

Johnson & Johnson Archives

Johnson & Johnson loses US$2.12bn baby-powder appeal bid

Missouri's highest court on Tuesday refused to consider Johnson & Johnson's appeal of a $2.12 billion damages award to w...

Nestlé to rename Australian lollies ‘out of step’ with values

Nestlé follows Colgate and Johnson & Johnson in reassessing brands following consumer pressure.

This week in FMCG

This week's top headlines.

J&J discontinues talc baby powder in US and Canada as lawsuits mount

J&J said it would wind down sales of the product, which makes up about 0.5 per cent of its US consumer health business, ...

This week in FMCG

Catch up on the top FMCG stories from this week.

This week in FMCG

This week's top headlines.

Johnson & Johnson pledges $600,000 for bushfire relief

J&J has also donated 200,000 personal care items in addition to its ongoing product donation program.

Major US retailers pull 22-ounce J&J baby powder from shelves

Retailers are being extra cautious with how they deal with J&J’s voluntary recall.

This week in FMCG

The top FMCG news from this week.

Johnson & Johnson recalls baby powder after asbestos found in sample

Around 33,000 bottles of baby powder recalled after health regulators found trace amounts of asbestos in samples.

Johnson & Johnson ordered to pay US$8 billion over Risperdal side effects

Plaintiff claims J&J's antipsychotic drug Risperdal can cause abnormal growth of female breast tissue in boys.

Johnson & Johnson cans CMO role as Alison Lewis departs

The consumer goods giant is streamlining priorities under a new business model.

This week in FMCG

The top headlines from this week.

J&J ordered to pay US$29m in talc trial

Latest defeat for the healthcare conglomerate which is facing over 13,000 similar lawsuits nationwide.

J&J forecasts sales to slow in 2019

The healthcare conglomerate beat expectations for the fourth quarter of 2018.

Latest J&J talc trial underway

Plaintiff alleges J&J talc product caused mesothelioma.

J&J CEO responds to asbestos report

Consumer goods company moves to reassure consumers that its products are safe.

J&J knew about asbestos in its baby powder for decades

The company withheld the information from regulators and the public.

J&J extends QUT collaboration

The three year extension will allow for continued life-science innovative research.

Johnson & Johnson addresses plastic waste problem

FMCG giant signs New Plastics Economy Global Commitment.